| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785ac2b35073f5a6d251678e6fb31b6f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-07049 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
| filingDate |
2000-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3631483bc67e3a86b7fabc4a3a52b063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e93d312053ba397134795d31e0d3c2b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c94d0774a35931b06092928515a09afc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0c269cc64aa7fdc82e1d7971db3d5d3 |
| publicationDate |
2002-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6492171-B2 |
| titleOfInvention |
Antisense modulation of TERT expression |
| abstract |
Antisense compounds, compositions and methods are provided for modulating the expression of TERT. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding TERT. Methods of using these compounds for modulation of TERT expression and for treatment of diseases associated with expression of TERT are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004110155-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7297488-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005070492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02101010-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11111525-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02101010-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003129626-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002193289-A1 |
| priorityDate |
2000-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |